The calendar may have flipped to April, but trade drama is still driving the markets. President Trump’s April 2 “Liberation ...

Mastering the calendar has never been easier! For its 150th anniversary, Audemars Piguet reinvents the perpetual calendar, one of its favorite historical complications. The new integrated caliber 7138 ...

This project has not set up a SECURITY.md file yet.

Illumina (ILMN) and Tempus AI (TEM) announced a collaboration to accelerate clinical adoption of next-generation sequencing tests through novel ...

BofA lowered the firm’s price target on Tempus AI (TEM) to $48 from $60 and keeps a Neutral rating on the shares. Sentiment for Life Sciences ...

CHICAGO, March 26, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will present at the 24th ...

Companies like Tempus AI TEM are leading the charge by leveraging AI for precision medicine. The stock’s 42.9% surge year to date strongly underscores a broader market shift—highlighting the ...

Tempus AI TEM and Doximity DOCS stand out as emerging players in the AI health tech space. These two offer distinct approaches to innovation and market disruption. Tempus AI is focused on ...

Financial giants have made a conspicuous bearish move on Tempus AI. Our analysis of options history for Tempus AI TEM revealed 9 unusual trades. Delving into the details, we found 44% of traders ...

Tempus AI started off the year with a stellar rally, but then bounced back from its peak in early February. There's no way this stock will remain cheap for long. Tempus AI's financials have ...